Azathioprine Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9566

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Azathioprine Sodium (NDC 0143-9566). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Azathioprine Sodium For Injection Usp 1)

Chemical structure of Azathioprine Sodium, showing the molecular arrangement including a purine base, a nitroimidazole group, and the sodium ion.*

FDA Label Image

Vial (Azathioprine Sodium For Injection Usp 2)

Azathioprine Sodium for Injection, USP 100 mg/vial, sterile lyophilized powder for intravenous use. The label includes dosage preparation instructions, storage conditions (20 to 25°C), and manufacturer info: THYMOORGAN PHARMAZIE GmbH, Germany, and distributor WEST-WARD, Eatontown, NJ USA. NDC 0143-9566-01. The label also emphasizes use under prescription and protecting from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.